Surface structure of fly ash particles. حسب Charles Sarala Rubi (21608723)

الموضوعات:

Elemental composition of Fly Ash. حسب Charles Sarala Rubi (21608723)

الموضوعات:

Composition of LM6 alloy. حسب Charles Sarala Rubi (21608723)

الموضوعات:

Image of the prepared sample (Pins and Disc). حسب Charles Sarala Rubi (21608723)

الموضوعات:

Micrograph of worn pin of LM6 alloy. حسب Charles Sarala Rubi (21608723)

الموضوعات:

Response graphs for GRG. حسب Charles Sarala Rubi (21608723)

الموضوعات:

Effect of B₄C& Fly ash on the hardness of AMCs. حسب Charles Sarala Rubi (21608723)

الموضوعات:

Survey-weighted association of flavonoids and six subclasses intake with MASLD. حسب Yuwei He (1565941)

الموضوعات:

Survey-weighted baseline characteristic of the study population by MASLD. حسب Yuwei He (1565941)

الموضوعات:

Weighted Quantile Sum model regression index weights for the MASLD. حسب Yuwei He (1565941)

الموضوعات:

Association between flavonoid intakes and metabolic dysfunction-associated steatotic liver disease (MASLD) using a Restricted Cubic Spline regression model, adjusted for age, sex,... حسب Yuwei He (1565941)

الموضوعات:

The flowchart of the sample selection from NHANES 2007-2010, 2017-2018. حسب Yuwei He (1565941)

الموضوعات:

Innovation and night light in large and small cities. حسب Saul Estrin (8629173)

Summary statistics of key variables. حسب Saul Estrin (8629173)

"…We find that in developing countries, as urban economic density increases, innovation first increases and then begins to decrease beyond a certain point, with the decline being most prominent in the largest cities. …"

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Flowchart of patient selection in this study. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

S1 Data - حسب Kazuyoshi Ohkawa (836847)

الموضوعات: